Important Safety Information

Avoid using the product for areas with thin skin such as the forehead and the area around the eyes, including the eyelids, dark circles under the eyes, etc, and areas with the exposed vascular system or with inflamed and infected skin. Avoid injection of the product simultaneously with laser therapy or deep chemical scaling in case of a significant inflammatory reaction. The product is not recommended for patients prone to hypertrophic scars, patients with a history of allergy to one of the ingredients, patients with a history of hyaluronic acid allergy (patients with a history of allergy to lidocaine), or local anesthesia of amide compounds. Avoid using Fiorage for people with porphyria, pregnant or lactating (breastfeeding) women, and children. It is important for doctors to obtain informed consent from the patient before treatment. Insertion of the needle in patients with a history of herpes may trigger a new course of herpes. The doctor should choose a corresponding treatment for patients with a history of autoimmune disease and constantly monitor their health condition during the treatment. It is recommended to avoid injection into allergic patients after performing initial skin allergic tests. Avoid injection of Fiorage in patients with acute rheumatic fever with cardiac complications. Given the presence of Lidocaine in Fiorage, this product is not recommended for patients taking liver metabolism-reducing or inhibiting drugs. Avoid injection into the areas with permanent implants. Use only the needles supplied in the package for the injection of Fiorage. Tell your doctor before treatment if you are using substances that can prolong bleeding, such as aspirin, or ibuprofen. As with any injection, this may result in increased bruising or bleeding at the injection site.